{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:40:49Z","timestamp":1775724049810,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014935","name":"BioCryst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017255","name":"Allergy Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017255","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009946","name":"Allergopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jaip.2020.03.041","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:59:53Z","timestamp":1586948393000},"page":"2322-2331.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Hendrik","family":"Nolte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne K.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kleine-Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.03.041_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1398-9995.2009.01975.x","article-title":"Ragweed sensitization in Europe\u2014GA(2)LEN study suggests increasing prevalence","volume":"64","author":"Burbach","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.041_bib2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaci.2010.12.1106","article-title":"Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"127","author":"Salo","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaci.2013.12.1071","article-title":"Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006","volume":"134","author":"Salo","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1398-9995.2009.02089.x","article-title":"GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe","volume":"64","author":"Burbach","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.041_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1289\/EHP173","article-title":"Climate change and future pollen allergy in Europe","volume":"125","author":"Lake","year":"2017","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jaip.2020.03.041_bib6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaci.2009.05.013","article-title":"Burden of allergic rhinitis: results from the Pediatric Allergies in America survey","volume":"124","author":"Meltzer","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib7","doi-asserted-by":"crossref","first-page":"w13253","DOI":"10.4414\/smw.2011.13253","article-title":"Time lag between Ambrosia sensitisation and Ambrosia allergy: a 20-year study (1989-2008) in Legnano, northern Italy","volume":"141","author":"Tosi","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaip.2020.03.041_bib8","first-page":"320","article-title":"Prevalence of ragweed hayfever in the south and east of the greater Lyon region in 1993 [in French]","volume":"27","author":"D\u00e9champ","year":"1995","journal-title":"Allerg Immunol (Paris)"},{"key":"10.1016\/j.jaip.2020.03.041_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3200\/AEOH.60.5.257-265","article-title":"Effect of weed pollen on children\u2019s hospital admissions for asthma during the fall season","volume":"60","author":"Im","year":"2005","journal-title":"Arch Environ Occup Health"},{"key":"10.1016\/j.jaip.2020.03.041_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.scitotenv.2006.06.019","article-title":"Analysis of short-term influences of ambient aeroallergens on pediatric asthma hospital visits","volume":"370","author":"Zhong","year":"2006","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jaip.2020.03.041_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2020.03.041_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/00325481.2017.1302306","article-title":"A\u00a0practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice","volume":"129","author":"Bernstein","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaip.2020.03.041_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/14740338.2015.1017468","article-title":"Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review","volume":"14","author":"Didier","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2020.03.041_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/alr.21707","article-title":"Patient preferences for route of allergy immunotherapy: a comparison of four delivery methods","volume":"6","author":"Chester","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.03.041_bib16","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40271-017-0217-0","article-title":"Development of a report card for identifying local sublingual immunotherapy events in clinical trials","volume":"10","author":"Norquist","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.jaip.2020.03.041_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00020310","article-title":"Mometasone furoate\/formoterol reduces asthma deteriorations and improves lung function","volume":"39","author":"Meltzer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.041_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11316220-000000000-00000","article-title":"Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence","volume":"12","author":"Milgrom","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaip.2020.03.041_bib23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite SLIT-tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib24","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.jaip.2018.01.037","article-title":"Impact of adverse event solicitation on the safety profile of SQ house dust mite sublingual immunotherapy tablet","volume":"6","author":"Nolte","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.03.041_bib25","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2014.01.030","article-title":"Esophageal hypereosinophilia induced by grass sublingual immunotherapy","volume":"133","author":"Antico","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib26","series-title":"Short ragweed pollen allergen extract tablet for sublingual use","year":"2014"},{"key":"10.1016\/j.jaip.2020.03.041_bib27","series-title":"Timothy grass pollen allergen extract tablet for sublingual use","year":"2014"},{"key":"10.1016\/j.jaip.2020.03.041_bib28","series-title":"Oralair. Sweet vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract tablet for sublingual use","year":"2014"},{"key":"10.1016\/j.jaip.2020.03.041_bib29","series-title":"House dust mite allergen extract tablet for sublingual use","year":"2017"},{"key":"10.1016\/j.jaip.2020.03.041_bib30","doi-asserted-by":"crossref","first-page":"AB173","DOI":"10.1016\/j.jaci.2017.12.552","article-title":"The prevalence of eosinophilic esophagitis with use of SQ HDM SLIT-tablet","volume":"141","author":"Maloney","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.041_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/all.12373","article-title":"Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure","volume":"69","author":"Durham","year":"2014","journal-title":"Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982030341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982030341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:23:16Z","timestamp":1761974596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982030341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S221321982030341X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.041","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}